US/EU regulators meet to advance MRA (mutual recognition agreement)
This article was originally published in Clinica
The European Commission has a meeting with a delegation from the US FDA and Department of Commerce this week on December 4 and 5 to discuss progress on the US/EU mutual recognition agreement (MRA). The first day will be a government to government meeting at the Commission's premises. The second day there will be a stakeholders meeting at the US mission in Brussels to the European Union.